NKCx Histopathological outcome* within 12 months after cervix cytology in 2018
501 Göteborg

  Benign CIN1 CIN2 CIN3 AIS Cancer Other PAD missing Total
Cytology Count Pct Count Pct Count Pct Count Pct Antal Andel Count Pct Count Pct Count Pct Count Pct
Benign sample 83 0.3% 18 0.1% . . 4 0.0% . . . . . . 24088 99.6% 24193 100.0%
ASCUS 513 17.5% 681 23.2% 4 0.1% 335 11.4% 2 0.1% 7 0.2% 13 0.4% 1376 46.9% 2931 100.0%
CIN1 89 17.2% 183 35.4% 1 0.2% 115 22.2% . . 1 0.2% . . 128 24.8% 517 100.0%
Atypical glandular cells/AGC 2 16.7% 4 33.3% . . 1 8.3% 3 25.0% 1 8.3% . . 1 8.3% 12 100.0%
Unclear atypia . . . . . . . . . . . . . . 1 100.0% 1 100.0%
ASC-H 15 13.6% 19 17.3% . . 71 64.5% 1 0.9% 1 0.9% . . 3 2.7% 110 100.0%
CIN2 . . . . . . 1 100.0% . . . . . . . . 1 100.0%
CIN3 18 6.2% 35 12.1% 2 0.7% 200 69.0% 7 2.4% 11 3.8% 1 0.3% 16 5.5% 290 100.0%
Adenocarcinoma . . . . . . 2 50.0% 1 25.0% 1 25.0% . . . . 4 100.0%
Total 720 2.6% 940 3.4% 7 0.0% 729 2.6% 14 0.0% 22 0.1% 14 0.0% 25613 91.3% 28059 100.0%

NOTE: Histopathological outcome from T83x taken into account.
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad.

* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead.
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'.
Process Registry's Class 1 (benign), 2d (CIN1) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories.
 

Snomed codes in the
category Cancer:
M80703, M81403